在肺移植后的支气管炎中Periostin Obliterans综合征
Hye Ju Yeo1,2, Junho Kang3, Yun Hak Kim4,5
1Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Transplant Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
International journal of molecular sciences
|October 16, 2024
概括
血清环素水平可以预测肺移植后的支气管炎消灭症综合征 (BOS). 较高的环素水平与肺功能减弱 (FEV1) 相相关,表明其作为BOS进展的生物标志物的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
- 移植科学 移植科学
背景情况:
- 支气管炎消灭综合征 (BOS) 是肺移植失败的主要原因.
- 预测性BOS生物标志物对于早期干预和改善患者结果至关重要.
- 血清环素在肺移植后BOS发展中的作用尚不清楚.
研究的目的:
- 调查血清环素水平在肺移植后预测BOS中的有用性.
- 评估肺移植接受者内素水平与肺功能下降 (FEV1) 之间的相关性.
主要方法:
- 在有或没有BOS的肺组织中对差异表达基因的分析.
- 97名肺移植患者在移植后1年和BOS发病时测量血清环素水平.
- 统计评估皮质素水平,BOS发生和FEV1下降之间的关联.
主要成果:
- 与对照组和稳定组相比,在BOS患者中观察到血清环素水平显著升高 (p < 0.001).
- 在BOS组中,在BOS发作时的皮洛斯水平显著高于移植后1年 (p < 0.001).
- 在BOS诊断时血清环素水平与FEV1减少正相关 (r = 0.745,p < 0.001),环素的增加与FEV1减少相关 (r = 0.753,p < 0.001).
结论:
- 血清内素显示出潜力作为肺移植后BOS发展的预测生物标志物.
- 在BOS患者中,升高的环素水平与肺功能障碍有关.
- 监测血清皮质素可能有助于管理患有BOS风险的肺移植接受者.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:27Pneumothorax-II
123
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
123